Evidence map›Paper›PMID 36146836›Full record

ArticleViruses2022

The Bovine Seminal Plasma Protein PDC-109 Possesses Pan-Antiviral Activity.

Hannah Sabeth Sperber, Kathrin Sutter, Karin Müller, Peter Müller, Roland Schwarzer

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hannah Sabeth SperberInstitute for Translational HIV Research, University Hospital Essen, Hufelandstraße 55, 45147 Essen, Germany.ORCID 0000-0002-9638-6555
Kathrin SutterInstitute for Translational HIV Research, University Hospital Essen, Hufelandstraße 55, 45147 Essen, Germany.ORCID 0000-0001-6397-6551
Karin MüllerLeibniz Institute for Zoo and Wildlife Research, Alfred-Kowalke-Straße 17, 10315 Berlin, Germany.
Peter MüllerDepartment of Biology, Humboldt-University Berlin, Invalidenstr. 42, 10115 Berlin, Germany.ORCID 0000-0003-4113-5043
Roland SchwarzerInstitute for Translational HIV Research, University Hospital Essen, Hufelandstraße 55, 45147 Essen, Germany.ORCID 0000-0002-7497-5180
Essen University Hospital · DEHumboldt-Universität zu Berlin · DELeibniz Institute for Zoo and Wildlife Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian seminal plasma contains a multitude of bioactive components, including lipids, glucose, mineral elements, metabolites, proteins, cytokines, and growth factors, with various functions during insemination and fertilization. The seminal plasma protein PDC-109 is one of the major soluble components of the bovine ejaculate and is crucially important for sperm motility, capacitation, and acrosome reaction. A hitherto underappreciated function of seminal plasma is its anti-microbial and antiviral activity, which may limit the sexual transmission of infectious diseases during intercourse. We have recently discovered that PDC-109 inhibits the membrane fusion activity of influenza virus particles and significantly impairs viral infections at micromolar concentrations. Here we investigated whether the antiviral activity of PDC-109 is restricted to Influenza or if other mammalian viruses are similarly affected. We focused on Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the etiological agent of the Coronavirus Disease 19 (COVID-19), thoroughly assessing PDC-109 inhibition with SARS-CoV-2 Spike (S)-pseudotyped reporter virus particles, but also live-virus infections. Consistent with our previous publications, we found significant virus inhibition, albeit accompanied by substantial cytotoxicity. However, using time-of-addition experiments we discovered a treatment regimen that enables virus suppression without affecting cell viability. We furthermore demonstrated that PDC-109 is also able to impair infections mediated by the VSV glycoprotein (VSVg), thus indicating a broad pan-antiviral activity against multiple virus species and families.

Indexed as

COVID-19SemenAnimalsAntiviral AgentsCattleCytokinesGlucoseHumansLipidsMaleMammalsSARS-CoV-2Seminal Plasma ProteinsSperm MotilitySpike Glycoprotein, CoronavirusAntiviral AgentsCytokinesGlucoseLipidsSeminal Plasma ProteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Bovine seminal plasmaFn-type 2 proteinsPDC-109SARS-CoV-2VSV replicon

Identifiers

PMID36146836
PMCPMC9504757
OpenAlexW4296764424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.